Welcome to our dedicated page for Zhongchao news (Ticker: ZCMD), a resource for investors and traders seeking the latest updates and insights on Zhongchao stock.
Zhongchao Inc. reports developments as a Cayman Islands holding company whose PRC operating entities provide platform-based healthcare information, education, training, patient management, and internet healthcare services in China. Its updates center on cancer and major-disease services, including the MDMOOC professional education platform, Zhongxin patient management programs, Zhixun Internet Hospital, and Sunshine Health Forums.
Recurring news themes include patient aid and medication assistance projects, disease management models for oncology and autoimmune conditions, healthcare professional education platforms, content partnerships for cancer education, and ordinary-share consolidations tied to Nasdaq listing compliance for ZCMD Class A ordinary shares.
Zhongchao (NASDAQ: ZCMD) will complete a 1-for-8 share consolidation effective with market open on March 2, 2026, and will retain the ticker ZCMD under a new CUSIP G9897X123.
Every eight Class A or Class B ordinary shares will be consolidated into one share; pre-consolidation outstanding shares were 25,754,124 Class A and 4,999,772 Class B, resulting in approximately 3,219,267 Class A and 624,972 Class B shares post-consolidation, subject to fractional-share rounding. The consolidation aims to regain compliance with Nasdaq Rule 5550(a)(2). The action was approved by shareholders and the board on February 10, 2026.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.